Picture of Iterum Therapeutics logo

ITRMF — Iterum Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Iterum Therapeutics Reports Q3 Net Income Of $3.7 Mln

Nov 12 (Reuters) - Iterum Therapeutics PLC  ITRM.O :
    * ITERUM THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * ITERUM THERAPEUTICS PLC - CASH RUNWAY INTO 2024
    * ITERUM THERAPEUTICS PLC - TYPE B MEETING WITH FDA
REQUESTED TO
AFFIRM DESIGN FOR ADDITIONAL PHASE 3 TRIAL NEEDED FOR
RESUBMISSION OF NDA FOR ORAL SULOPENEM
    * ITERUM THERAPEUTICS PLC - FOR Q3 OF 2021, ITERUM REPORTED
NET
INCOME OF $3.7 MILLION

Source text for Eikon:  ID:nGNXc2Zcpy 
Further company coverage:  ITRM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Iterum Therapeutics

See all news